ATOSSA THERAPEUTICS, INC. Current Federal Tax Expense (Benefit)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Current Federal Tax Expense (Benefit) of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2016-03-30
- ATOSSA THERAPEUTICS, INC. current federal tax expense (benefit) for fiscal 2015 was $0.00.
- ATOSSA THERAPEUTICS, INC. current federal tax expense (benefit) for fiscal 2014 was $0.00.
- ATOSSA THERAPEUTICS, INC. current federal tax expense (benefit) for fiscal 2013 was $0.00.
| Period end | Current Federal Tax Expense (Benefit) 12 month |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-30 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |